Sub Banner Image

Eli Lilly’s Obesity Pill Moves Closer to Approval

Markets

·

August 26, 2025

·

Bloomberg

Eli Lilly & Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval. Damian Garde has more on “Bloomberg Open Interest.”

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.